Bio Plus Co., Ltd (099430.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	99.2B	90.9B	66.4B	65.0B	56.7B
Cost of Revenue	31.7B	30.3B	23.8B	25.5B	22.9B
Gross Profit	67.5B	60.6B	42.6B	39.6B	33.8B
Operating Expenses
R&D Expense	3.6B	3.4B	1.5B	1.2B	1.1B
SG&A Expense	36.5B	22.4B	6.6B	3.2B	2.7B
General & Admin Expense	6.4B	7.1B	1.5B	1.0B	660.7M
Selling & Marketing Expense	13.5B	15.3B	5.1B	2.2B	2.1B
Other Expenses	16.6B	19.8B	10.9B	7.2B	4.7B
Total Operating Expenses	49.7B	45.6B	19.0B	11.5B	8.5B
Cost and Expenses	81.4B	75.9B	42.7B	37.0B	31.4B
Operating Income (EBIT)	17.7B	15.0B	23.7B	28.0B	25.3B
Non-Operating
Interest Income	17.0B	22.3B	1.8B	2.4B	1.1B
Interest Expense	16.8B	19.5B	263.4M	60.3M	13.3M
Net Interest Income	138.0M	2.8B	1.5B	2.4B	1.1B
Other Non-Op Income/Expense	(247.8M)	2.5B	(6.0B)	4.7B	2.2B
Non-Operating Income (excl Interest)	(1.9B)	(2.8B)	5.7B	(4.8B)	826.7M
EBT (Pre-Tax Income)	17.5B	17.5B	17.7B	32.7B	27.5B
Income Tax Expense	(2.3B)	(2.5B)	153.1M	5.3B	6.8B
Bottom Line
Net Income	13.8B	15.0B	14.2B	25.6B	21.1B
Earnings from Cont. Ops	19.8B	20.0B	17.5B	27.4B	20.7B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	13.8B	15.0B	14.2B	25.6B	21.1B
Per Share
Basic EPS	₩228	₩253	₩250	₩445	₩372
Diluted EPS	₩221	₩149	₩247	₩433	₩371
Revenue Per Share	₩1,618	₩1,533	₩1,174	₩1,131	₩977
Shares
Basic Shares Outstanding	61.3M	59.3M	56.6M	57.5M	58.1M
Diluted Shares Outstanding	61.3M	61.5M	56.6M	59.1M	58.1M
Profitability Metrics
EBITDA	23.7B	21.9B	21.2B	30.5B	27.5B
D&A	4.5B	4.1B	3.3B	2.5B	1.9B
EBIT	20.1B	17.8B	17.9B	28.0B	25.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026